Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

<p>Source Data</p>

保存先:

書誌詳細
第一著者:	Takeru Oka (15386810) (author)
その他の著者:	Tsunaki Higa (15386813) (author), Osamu Sugahara (15386816) (author), Daisuke Koga (15386819) (author), Shogo Nakayama (15386822) (author), Keiichi I. Nakayama (9625916) (author)
出版事項:	2025
主題:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Cell Cycle CDKs and CDK inhibitors Drug Resistance Novel mechanisms Gastrointestinal Cancers Colorectal cancer Stem Cell Biology Cancer stem cells Tumor Heterogeneity
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
著者:: Takeru Oka (15386810)
出版事項: (2025)

Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
著者:: Emmanuel Griessinger (16721087)
出版事項: (2025)

Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
著者:: Emmanuel Griessinger (16721087)
出版事項: (2025)

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
著者:: Xiaoqing Cheng (16918496)
出版事項: (2025)

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
著者:: Xiaoqing Cheng (16918496)
出版事項: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
著者:: Xiaoqing Cheng (16918496)
出版事項: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
著者:: Xiaoqing Cheng (16918496)
出版事項: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
著者:: Xiaoqing Cheng (16918496)
出版事項: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
著者:: Xiaoqing Cheng (16918496)
出版事項: (2025)

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
著者:: Reza Mirzaei (15306062)
出版事項: (2025)

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
著者:: Reza Mirzaei (15306062)
出版事項: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
著者:: Reza Mirzaei (15306062)
出版事項: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
著者:: Ana Vujovic (15207479)
出版事項: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
著者:: Lanpeng Chen (16918293)
出版事項: (2025)

Table 2_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
著者:: Sushmitha Rajeev Kumar (22687190)
出版事項: (2025)

Table 1_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
著者:: Sushmitha Rajeev Kumar (22687190)
出版事項: (2025)

Video 2_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
著者:: Minxia Ke (4889887)
出版事項: (2025)

Data Sheet 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.docx
著者:: Minxia Ke (4889887)
出版事項: (2025)

Video 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
著者:: Minxia Ke (4889887)
出版事項: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
著者:: Zhongyi Zhang (219440)
出版事項: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
著者:: Zhongyi Zhang (219440)
出版事項: (2025)

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
著者:: Natalia Colomar-Carando (14611340)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_q56dgeflsnnser7s86l6aje63v